Added to YB: 2023-04-02
Pitch date: 2023-04-02
QNCX [bullish]
Quince Therapeutics, Inc.
+129.81%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
Market Cap
$91.9M
Pitch Price
$1.61
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.01
P/E
-1.41
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
QUINCE THERAPEUTICS INC QNCX
A summary for this pitch has not been created yet.
Read full article (0 min)